Table 3.

Solid cancers frequency according to vitamin B12 interval and to the presence of metastases.

Vitamin B12 (ng/L)	0–749	750–999	1000–1249	1250–1749	≥1750
No cancer (n, %)	665/719 (92.5%)	56/66 (84.8%)	246/285 (86.3%)	211/268 (78.7%)	176/232 (75.9%)
Cancer without metastases (n, %)	23/719 (3.2%)	8/66 (12.1%)	14/285(4.9%)	23/268 (8.6%)	15/232 (6.5%)
Cancer with metastases(n, %)	31/719 (4.3%)	2/66 (3.0%)	25/285(8.8%)	34/268 (12.7%)	41/232 (17.7%)

The distributions differed between the subgroups with vitamin B12 elevation (p < 0.0001).